9 patents
Utility
Peptide pharmaceuticals for treatment of NASH and other disorders
3 Jan 23
The disclosure provides peptide products comprising a peptide covalently attached to a surfactant moiety which have improved properties, including increased duration of action and bioavailability.
John J Nestor
Filed: 3 Jan 19
Utility
Biodegradable polymeric particles encapsulating an active agent, pharmaceutical compositions and uses thereof
26 Jul 22
Therapeutic or prophylactic compositions providing an active agent, such as an antigen or a vector that contains and expresses an antigen, encapsulated in or incorporated into a biodegradable polymeric particle are provided.
Allan E. David, Henry J. Baker, Aime K. Johnson, M. Scot Roberts, Kent R. Van Kampen, Prachi Sangle
Filed: 15 Sep 17
Utility
Coronavirus immunogenic compositions and uses thereof
12 Jul 22
Provided in the present disclosure are immunogenic compounds, pharmaceutical formulations thereof and their use for inducing a protective immune response against 2019 novel coronavirus (SARS-CoV-2) infection and variants in a mammal.
Bertrand Victor Gilbert Georges, M. Scot Roberts
Filed: 9 Jun 21
Utility
Rapid and prolonged immunologic-therapeutic
12 Oct 21
The present invention shows that intranasal administration of E1/E3-defective adenovirus particles may confer rapid and broad protection against viral and bacterial pathogens in a variety of disease settings.
De-chu C Tang
Filed: 28 Mar 21
Utility
Rapid and prolonged immunologic therapeutic
22 Jun 21
The present invention shows that intranasal administration of E1/E3-defective adenovirus particles may confer rapid and broad protection against viral and bacterial pathogens in a variety of disease settings.
De-Chu C Tang
Filed: 11 Jul 20
Utility
Rapid and prolonged immunogic therapeutic
22 Jun 21
The present invention shows that intranasal administration of E1/E3-defective adenovirus particles may confer rapid and broad protection against viral and bacterial pathogens in a variety of disease settings.
De-Chu C Tang
Filed: 12 Jul 20
Utility
Immunogenic compound
30 Nov 20
The present application relates to an immunostimulatory compound comprising an immunostimulant portion and a peptide portion.
Bertrand Georges
Filed: 6 Oct 19
Utility
Immunization of avians by administration of non-replicating vectored vaccines
17 Aug 20
The present invention relates generally to the fields of immunology and vaccine technology.
De-Chu C. Tang, Kent R. Van Kampen, Haroldo Toro
Filed: 27 Nov 17
Utility
Fluorocarbon-linked peptide formulation
3 Aug 20
The invention provides an aqueous acidic formulation suitable for use as in the preparation of a pharmaceutically acceptable fluorocarbon-linked peptide formulation, which aqueous formulation comprises a first fluorocarbon-linked peptide, wherein: the peptide linked to the fluorocarbon is at least 20 amino acid residues long, comprises at least 50% hydrophobic amino acid residues and has an isoelectric point greater than or equal to 7; and the fluorocarbon-linked peptide is present in micelles.
Carlton Bradley Brown, Bertrand Victor Gilbert Georges, Jean Francois Thaburet
Filed: 22 Jul 15
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first